Bottom line
Is MGXAX a good fund? The bottom line
MGXAX is the Class A share class of NYLI Equity Allocation Fund, an actively managed allocation / balanced mutual fund from New York Life Investments.
Annual fees run 0.99% — about $99 a year on every $10,000 invested, more expensive than 58% of allocation / balanced funds we track.
It returned +10.6% over one year, +7.5% a year over five years, +8.5% a year over ten (as of Dec 31, 2025, per its prospectus).
With $502 million in net assets and 28 holdings, its largest position is NYLIM Candriam U.S. Mid Cap Equity ETF (10.5%) and the top 10 make up 70.9% of the portfolio.
This share class carries a front-end sales charge of up to 3%; a no-load class or ETF alternative can avoid it.
What stands out
- 5-year return beat 77% of category peers
What to watch
- Concentrated: top 10 holdings are 70.9% of assets
- Front-end sales load up to 3%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What MGXAX invests in
The Fund seeks long-term growth of capital.
"The Fund is a ""fund of funds"" that seeks to achieve its investment objective by investing in mutual funds and exchange-traded funds managed by New York Life Investment Management or its affiliates (the ""Underlying Funds""). The Underlying Funds are described and offered for direct investment in separate prospectuses. The Fund is designed for investors with a particular risk profile as represented by the asset class allocations described below, and invests in a distinct mix of Underlying Funds. The Fund seeks to achieve its investment objective by normally investing substantially all of its assets in Underlying Equity Funds (normally within a range of 90% to 100%). The Fund may invest approximately 25% (within a range of 15% to 35%) of its assets in Underlying International Equity Funds. The Fund may invest up to 10% of its assets in Underlying Fixed-Income Funds. New York Life…
From the fund's prospectus (filed Feb 26, 2026).
MGXAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MGXAX | +10.6% | +7.5% | +8.5% |
| Allocation / Balanced median | +11.0% | +5.7% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2025
What MGXAX costs
On a $10,000 investment, MGXAX's 0.99% expense ratio costs about $99 a year. The prospectus estimates $1,477 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.
MGXAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | NYLIM Candriam U.S. Mid Cap Equity ETF | 10.49% |
| 2 | NYLIM US Large Cap R&D Leaders ETF | 8.61% |
| 3 | NYLIM Candriam U.S. Large Cap Equity ETF | 8.22% |
| 4 | NYLIM WMC Growth Fund | 7.54% |
| 5 | NYLIM WMC Small Companies Fund | 7.34% |
| 6 | NYLIM Candriam International Equity ETF | 6.19% |
| 7 | NYLIM S&P 500 Index Fund | 5.88% |
| 8 | NYLIM Epoch International Choice Fund | 5.70% |
| 9 | NYLIM WMC Value Fund | 5.61% |
| 10 | NYLIM Epoch U.S. Equity Yield Fund | 5.35% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 70.9% of the fund. See all top 25 holdings and asset mix →